Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceu...
Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%
Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%
Rundu Pharma released its performance for the first three quarters, with a net loss attributable to the parent company of 54.6878 million yuan
Rundu Pharma: Application for the listing of isosorbide mononitrate chemical raw materials has been approved
Rundu Pharma: Passed the on-site inspection by the European Medicines Agency
Rundu Pharma: Valsartan Amlodipine Tablets (I) Obtains Drug Registration Certificate